Sorafenib combined with percutaneous radiofrequency ablation for the treatment of medium-sized hepatocellular carcinoma

Research output: Contribution to journalArticle

6 Citations (Scopus)
Original languageEnglish
Pages (from-to)2521-2522
Number of pages2
JournalEuropean Review for Medical and Pharmacological Sciences
Volume19
Issue number14
Publication statusPublished - 2015

ASJC Scopus subject areas

  • Medicine(all)
  • Pharmacology (medical)

Cite this

@article{e9afe8b5b5244d669f0a818b2018f448,
title = "Sorafenib combined with percutaneous radiofrequency ablation for the treatment of medium-sized hepatocellular carcinoma",
author = "M. Berretta and {Di Francia}, R. and U. Tirelli",
year = "2015",
language = "English",
volume = "19",
pages = "2521--2522",
journal = "European Review for Medical and Pharmacological Sciences",
issn = "1128-3602",
publisher = "Verduci Editore",
number = "14",

}

TY - JOUR

T1 - Sorafenib combined with percutaneous radiofrequency ablation for the treatment of medium-sized hepatocellular carcinoma

AU - Berretta, M.

AU - Di Francia, R.

AU - Tirelli, U.

PY - 2015

Y1 - 2015

UR - http://www.scopus.com/inward/record.url?scp=84942324213&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84942324213&partnerID=8YFLogxK

M3 - Article

C2 - 26221876

AN - SCOPUS:84942324213

VL - 19

SP - 2521

EP - 2522

JO - European Review for Medical and Pharmacological Sciences

JF - European Review for Medical and Pharmacological Sciences

SN - 1128-3602

IS - 14

ER -